Related Experiment Videos
Phenelzine produces subsensitivity to nicotine
S C Dilsaver1, M Hariharan, R K Davidson
1Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Texas, Houston.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|September 1, 1993
Summary
Phenelzine treatment significantly reduced the hypothermic effect of nicotine in rats, suggesting a potential link between nicotinic mechanisms and antidepressant drug actions. Further studies in humans may be warranted.
Area of Science:
- Neuropharmacology
- Animal Models of Disease
- Drug Metabolism
Background:
- Phenelzine is a monoamine oxidase inhibitor used to treat depression.
- Nicotine affects physiological responses, including body temperature.
- Understanding drug interactions with nicotinic systems is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effect of phenelzine on nicotine-induced hypothermia in a rat model.
- To explore the potential relationship between phenelzine, nicotine, and affective illness treatments.
Main Methods:
- Sprague Dawley rats (n=10) received phenelzine sulfate (15.0 mg/kg) every 48 hours for 14 days.
- The hypothermic response to nicotine was measured.
- Nicotine elimination rates were assessed.
Main Results:
- Phenelzine treatment resulted in a 73.3% decrease in the hypothermic response to nicotine.
- Phenelzine did not alter the rate of nicotine elimination.
- Findings suggest phenelzine modulates nicotine's physiological effects.
Conclusions:
- Phenelzine alters the hypothermic response to nicotine in rats.
- The study supports further investigation into nicotinic mechanisms and antidepressant therapies.
- Animal model findings suggest potential for human subject studies.